Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,306.40 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Natco Pharma share price stands at ₹795.65 as of 11.45 am on March 3, 2025. This reflects a gain of 3.22% from the previous close of ₹770.70. Let’s delve deeper into the current market trends, ...

A division bench of the Delhi High Court on Wednesday asked Natco Pharma to pause the launch of its drug Risdiplam till April 2 amid a patent dispute with Swiss pharmaceutical giant F Hoffmann-La ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Remaining water in the common reservoirs of Srisailam and Nagarjuna Sagar should be used efficiently, advises the Board’s Chairman A proposal for construction of the new airport at Nagarjuna Sagar has ...

A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.

Cash Taxes Paid 286.30 177.50 48.20 130.00 ...

The Delhi High Court on Monday rejected Swiss multinational F. Hoffmann-La Roche AG’s petition seeking to temporarily restrain Natco Pharma from infringing its product patent for Risdiplam compound ...

The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La Roche AG against Indian drugmaker Natco Pharma Limited alleging that the ...